Profile_bird

Hey there! Novartis is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What are you doing? Join today to start receiving Novartis's tweets.

Already using Twitter
from your phone? Click here.

Novartis

  1. @VinumVine Apologies for the delay in responding. Thanks for your understanding7:39 AM Nov 7th from Seesmic in reply to VinumVine
  2. @VinumVine Thx for your Q. For H1N1 vac., Novartis on track for US delivery http://bit.ly/3qg86P Seasonal flu delivered http://bit.ly/3EtGp47:38 AM Nov 7th from Seesmic in reply to VinumVine
  3. Celtura approval is key step toward replacing 50 year-old egg-based flu vaccine production w/ modern biotechnology http://bit.ly/2SHynD1:00 AM Nov 5th from Seesmic
  4. Clinical trials in more than 1850 individuals across all age groups show strong efficacy for Celtura http://bit.ly/2SHynD11:54 PM Nov 4th from Seesmic
  5. Novartis receives German regulatory approval for Celtura®, 1st adjuvanted cell culture-based A(H1N1) flu vaccine http://bit.ly/2SHynD10:34 PM Nov 4th from Seesmic
  6. Novartis opens $250M advanced technical R&D & manuf. facility in Changshu, furthering economic dev. of Jiangsu province http://bit.ly/2xz5rH12:38 PM Nov 3rd from web
  7. Novartis Institute of BioMedical Research in Shanghai to research new meds to treat highly prevalent diseases in China http://bit.ly/2xz5rH7:19 AM Nov 3rd from Seesmic
  8. Novartis to invest $1Bio to build largest pharmaceutical R&D institute in China http://bit.ly/2xz5rH6:47 AM Nov 3rd from Seesmic
  9. Novartis is proud to be ranked one of the top 50 "world's most attractive employers." http://bit.ly/wBCkA8:41 AM Oct 30th from web
  10. New Novartis biological therapy approved in EU to treat patients with CAPS, a rare auto-inflammatory disease http://bit.ly/3rl3EN11:42 PM Oct 27th from mobile web
  11. Novartis thanks the readers of MedAdNews for naming us "most admired pharmaceutical company" http://bit.ly/6BSDH9:21 AM Oct 23rd from web
  12. Novartis receives approval in EU for new 3-in-1 once-daily single pill to treat patients with high blood pressure http://bit.ly/2TLyTf10:32 PM Oct 22nd from web
  13. Q3 Analyst webcast (slides/audio) starting now. Follow it here: http://bit.ly/1yt33p5:02 AM Oct 22nd from web
  14. Novartis delivers strong new product momentum and operational performance in first 9 mos. of 2009 http://bit.ly/2Dlbp610:13 PM Oct 21st from web
  15. We will announce our Q3 results tomorrow, Oct 22. Analyst webcast starts 2pm CET. More to come here http://bit.ly/1yt33p7:07 AM Oct 21st from web
  16. New Novartis Phase II study results announced for treatment of patients with chronic gout http://bit.ly/1utmwZ4:58 AM Oct 20th from Seesmic
  17. Novartis committed to therapies for multiple sclerosis community #multiplesclerosis #MS #MSmonday http://bit.ly/3YhDXW9:20 PM Oct 19th from web
  18. RT @MalariaNoMore You’ve heard of Text to Give - but how about Text to Live? http://bit.ly/UqwL02:11 PM Oct 14th from web
  19. CHMP positive opinion for QAB149 in patients with COPD, a life-threatening respiratory disease http://bit.ly/2DmQ39:17 AM Sep 25th from web
  20. Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren http://twurl.nl/samel412:52 AM Sep 18th from web
  • Name Novartis
  • Location Switzerland
  • Web http://novartis.com
  • Bio Latest Novartis news and updates from Novartis Communications
10 Following 3,490 Followers 73 Listed
Sandoz Brasil CDC Flu Pandemic Flu BirdFluGov Bird Flu/Swine Flu Health Dr. Sanjay Gupta BBC Health CDC Emergency WHO News